EBIT: Income before interest and taxes.
AC Immune (ACIU) had EBIT of $-12.07M for the most recently reported fiscal quarter, ending 2026-09-30.
| Income Statement Financials | |
$3.99M |
|
$-10.77M |
|
-- |
|
$3.99M |
|
$16.06M |
|
$-12.07M |
|
$1.29M |
|
$-10.77M |
|
$-10.77M |
|
$-10.77M |
|
$-10.77M |
|
$-10.77M |
|
$-10.77M |
|
|
EBIT |
$-12.07M |
-- |
|
67.31M |
|
67.31M |
|
$-0.16 |
|
$-0.16 |
|
| Balance Sheet Financials | |
$101.71M |
|
$2.16M |
|
$69.69M |
|
$171.41M |
|
$120.25M |
|
-- |
|
$17.98M |
|
$138.23M |
|
$33.18M |
|
$-28.90M |
|
$33.18M |
|
-- |
|
| Cash Flow Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|